Trial Profile
A trial to assess the effect of sitagliptin on T lymphocytes and monocytes in patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Nov 2014
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 12 Nov 2014 New trial record
- 18 Sep 2014 Results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.